Neuphoria Therapeutics Inc.
NEUP
$4.19
-$0.18-4.12%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.47M | -369.60K | 5.83M | -8.21M | -10.82M |
| Total Depreciation and Amortization | 662.90K | 662.80K | 662.90K | 663.20K | 662.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.43M | 280.80K | -5.93M | -6.17M | -4.26M |
| Change in Net Operating Assets | 2.10M | -496.80K | 87.60K | -375.70K | -259.80K |
| Cash from Operations | 715.70K | 77.20K | 651.50K | -14.10M | -14.68M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.78M | 1.53M | 2.45M | 3.56M | 3.85M |
| Repurchase of Common Stock | -400.00 | -400.00 | -400.00 | -400.00 | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 227.70K | 0.00 | 5.50M | 4.97M | 10.42M |
| Cash from Financing | 5.01M | 1.53M | 7.95M | 8.53M | 14.27M |
| Foreign Exchange rate Adjustments | -161.60K | -3.70K | 19.10K | -251.80K | 368.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.56M | 1.60M | 8.62M | -5.82M | -47.10K |